EATG » Scientific research

Scientific research

Defective HIV proviruses hinder immune system response and cure

Mutant forms of HIV complicate disease monitoring and distract the immune system from the functional virus Researchers at Johns Hopkins and George Washington universities report new evidence that proteins created…

New HIV reservoir discovered

Findings reveal a second target for cure research. Chapel Hill, NC – HIV cure research to date has focused on clearing the virus from T cells, a type of white…

We asked a scientist to explain CRISPR to us—and how it’s being used in HIV research

Perhaps you’ve heard about a research technology called CRISPR (pronounced “crisper”) in the news. Since the technology was first developed, it has generated headlines as thousands of researchers have adopted…

Understanding of herpesvirus infection advanced by new research

Protein complexes identified that control infection and reactivation Herpes simplex virus (HSV) infections last a lifetime. Once a person has been infected, the virus can remain dormant (latent) for years…

New approach makes cells resistant to HIV

TSRI and City of Hope team up in effort to cure AIDS LA JOLLA, CA – April 10, 2017 – Scientists at The Scripps Research Institute (TSRI) have found a…

Scientist awarded $4.8 million to bring HIV vaccine closer to human trials

JUPITER, FL – April 11, 2017 – Professor Michael Farzan, co-chair of the Department of Immunology and Microbiology on the Florida campus of The Scripps Research Institute (TSRI) has received…

Researchers trace origin of blood-brain barrier ‘sentry cells’

Finding in zebrafish may contribute to understanding cognitive decline of aging National Institutes of Health researchers studying zebrafish have determined that a population of cells that protect the brain against…

Financial math may help build a better HIV vaccine

Microbiologists accurately predict evolution of HIV surface proteins using concepts from stock price prediction models What do particle diffusion in liquids and stock price prediction have to do with building…

ABIVAX initiates clinical trial (ABX464-005) to evaluate the effect of ABX464 on HIV reservoirs in HIV patients

First patient enrolled The study seeks to unveil the biological mechanism of ABX464 behind the prolonged period before viral rebound occurs, seen in preclinical models Initial results are expected in…

New $1.5 million NIH grant targets oral complications of HIV

More than a third of HIV patients develop oral conditions from immune systems compromised by the virus and its treatment, according to the National Institutes of Health (NIH) While advances…